Article Details
Retrieved on: 2022-04-06 20:51:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... SARS-CoV-2 hyperimmune globulin "may reduce the risk for severe COVID-19 and can be used when no monoclonal antibody therapies are available," ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here